USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Growing Competitive Intensity is Driving Pharma Digitization, Building Unique Growth Opportunities
22-Apr-2024
Global
Market Outlook
PFDE-01-00-00-00
CM_2024_671
Frost & Sullivan identifies and defines the leading trends shaping the global pharmaceutical landscape in this analysis. The study period is 2021–2028, with 2023 as the base year and 2024–2028 as the forecast period. The geographic scope includes 5 regions: North America, Latin America (LATAM) and the Caribbean, Asia-Pacific (APAC), Europe, and the Middle East and Africa. Chemicals/Small molecules and biologics are the 2 segments covered.
Other information covered include:
• Pharmaceutical industry overview
• Revenue forecasts by segment
• The top 5 predictions for 2024 and beyond
• Macro and micro trends driving the industry’s future
• R&D expenditure and leading therapeutic areas
• Growth opportunities
After a plateaued growth in 2023 due to the biologics segment slowdown and a decrease in the uptake of COVID-19 vaccines and therapeutics, the industry will likely realign its growth to record a 5.9% CAGR between 2023 and 2028. Year-on-year (YoY) growth will remain low in developed economies, including the United States and Europe. In contrast, emerging economies in APAC, LATAM, and the rest of the world will register comparatively stronger single-digit YoY growth.
The recession and ongoing inflation will remain pressing challenges for the pharmaceutical industry in 2024, affecting returns on investment. Pharmaceutical companies will continue to shift toward regional rather than global suppliers to ensure geographic proximity and a smoother, more reliable supply chain.
There continues to be a strong focus on environmental, social, and governance commitments and supply-chain digitalization through lighthouse manufacturing techniques, decentralized clinical trial approaches, and the application of artificial intelligence. The industry is also witnessing a healthy mergers and acquisitions landscape, with several successful transactions recently. In addition, Frost & Sullivan expects a rebound in initial public offerings (IPOs), with 5 IPOs completed by February 2024.
Author: Aarti Siddhesh Chitale
Highlights
Top Predictions for 2024
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Global Pharmaceutical Industry
Segmentation and Scope
Key Industry Themes
Trend 1: Increasing M&As in Biopharma
Trend 1: Increasing M&As in Biopharma (continued)
Trend 2: Higher Focus on Precision Medicine
Trend 2: Higher Focus on Precision Medicine (continued)
Trend 3: More RWE Integration in Drug R&D
Key Trend 3: More RWE Integration in Drug R&D (continued)
Global Pharmaceutical Industry—R&D Expenditure Outlook
Global Drug Development Pipeline by Development Phase
Key Therapeutic Area Outlook
Key Therapeutic Area Outlook (continued)
Top 10 Trends for 2024
Top 10 Growth Opportunities
Global GDP Growth—Global Growth will See a Mild Slowdown from 3% in 2023 to 2.6% in 2024 as Major Economies Lose Momentum
Inflation and Interest Rates—Headline Inflation will Continue to Decline. H2 2024 will Shift Toward Rate Cuts for Advanced Economies
Currency Trajectory—The Dollar will Remain Strong in H1 2024. Emerging Market Currencies will Receive a Boost From Q3 2024
Oil Markets—OPEC+ will Cut Oil Production in Q1. Non-OPEC Production will Increase
Labor Market—Unemployment will See a Moderate Uptick. Positive Expectations Over Market Sentiment will Support Labor Hoarding
Critical Mineral Supplies—The Need for Economic Resiliency will Bolster Cross-border and Cross-industry Partnerships
North America—The Region will See an Economic Slowdown Amidst a Discretionary Spending Pullback and Elevated Interest Rates
Western Europe—The Region will See a Moderate Growth Pick-up as Inflation Headwinds Ease. Rebuilding Fiscal Buffers will Take Precedence
The Middle East—Economic Diversification will Drive Non-oil Growth to Limit the Pullback From a Slowdown in Global oil Markets
Asia—Emerging Economies will Drive Growth Momentum. Fiscal Measures will Support CHINESE Economic Recovery
High Inflation and Global Recession
High Inflation and Global Recession (continued)
Intensification of Supply Chain Resilience Strategies
Intensification of Supply Chain Resilience Strategies (continued)
Sustainability Across the Pharma Value Chain
Sustainability Across the Pharma Value Chain (continued)
Global Pharmaceutical Industry—Historic Sales and Forecast
Segment Performance—Historic Sales and Forecast
Segment Performance—Historic Sales and Forecast (continued)
Revenue Forecast by Region
Revenue Forecast Analysis by Region
Regional Regulatory Trends—North America
Regional Regulatory Trends—Europe
Regional Regulatory Trends—Europe (continued)
Regional Regulatory Trends—APAC
Regional Regulatory Trends—APAC, LATAM, the Caribbean, the Middle East, and Africa
Prediction 1
Prediction 2
Prediction 3
Prediction 4
Prediction 5
Small Molecules Snapshot—2024
Small-molecule Companies to Watch
Biologics Snapshot—2024
Biologics Companies to Watch
Growth Opportunity 1: Scale Precision Oncology in Asia-Pacific Through Public-private Partnership Models
Growth Opportunity 1: Scale Precision Oncology in Asia-Pacific Through Public-private Partnership Models (continued)
Growth Opportunity 2: Target Undruggable Proteins with Emerging Biotech Platforms
Growth Opportunity 2: Target Undruggable Proteins with Emerging Biotech Platforms (continued)
Growth Opportunity 3: Develop Agile Partnership Models for Drug Discovery and Development
Growth Opportunity 3: Develop Agile Partnership Models for Drug Discovery and Development (continued)
Best Practices Recognition
Frost Radar
Benefits and Impacts of Growth Opportunities
Next Steps
Take the Next Step
List of Exhibits
Legal Disclaimer
List of Figures
- Increasing M&As in Biopharma: Implications for Key Stakeholders, Global, 2023–2028
- Higher Focus on Precision Medicine: Implications for Key Stakeholders, Global, 2023–2028
- RWE Integration in Drug R&D: Implications for Key Stakeholders, Global, 2023–2028
- Pharmaceutical Industry: R&D Expenditure Forecast, Global, 2021–2028
- Pharmaceutical Industry: Drug Development Pipeline by Clinical Phase, Global, 2022–2023
- Pharmaceutical Industry: Therapeutic Segment Share, Global, 2024
- Pharmaceutical Industry: Therapeutic Segment Share, Global, 2028
- High Inflation and Global Recession: Implications for Key Stakeholders, Global, 2023–2028
- Intensification of Supply Chain Resilience Strategies: Implications for Key Stakeholders, Global, 2023–2028
- Sustainability Across the Pharma Value Chain: Implications for Key Stakeholders, Global, 2023–2028
- Pharmaceutical Industry: Revenue Forecast by Segment, Global, 2023 and 2024
- Pharmaceutical Industry: Revenue Forecast by Scenario, Global, 2021–2028
- Biologics: Revenue Forecast, Global, 2021–2028
- Small Molecules: Revenue Forecast, Global, 2021–2028
- Pharmaceutical Industry: Revenue Forecast by Region, Global, 2023–2024
Speak directly with our analytics experts for tailored recommendations.
Recent related Chemicals and Materials research
09 Oct 2026 | Global | Technology Research
Innovations in Transparent Ceramics, Biomaterials, Compostable Bioplastics, Graphite, Silica Foam, Aerogels, and Other Advanced Materials for Diverse Applications
This issue of High-Tech Materials Technology Opportunity Engine (TOE) profiles significant advances in high-tech materials for various industrial applications. The featured innovations include Large-sized Transparent and Bonded Ceramics for High-Power Laser Systems, High-Strength Transparent Alumina...
08 Oct 2026 | South Asia, Middle East & North Africa | Market Research
Growth Opportunities for Sulphur Derivatives in MENA, 2025–2030
The MENA region plays a critical role in global sulphur supply; however, a significant share of value creation remains concentrated in exports and commodity derivatives. As global demand evolves and advanced applications for sulphur-based products gain momentum, the region’s competitive advantage li...
05 Oct 2026 | Global | Market Research
Impact of GLP-1 on Nutraceuticals, Global, 2025–2032
The rapid adoption of GLP-1 therapies is reshaping the weight management landscape and creating a new set of nutritional needs among consumers using these treatments. While GLP-1 therapies have demonstrated significant benefits for weight loss and metabolic health, associated challenges—including re...
02 Oct 2026 | Global | Technology Research
Innovations in Nanotechnology Including Nanocoatings, Nanolithography, Carbon Nanotubes, Nanofluids, Graphene, Ceramic Aerogels, Nanocatalysts, and Nanocomposites
This issue of the Nanotechnology Opportunity Engine profiles significant advances in nanotechnology for various industrial applications. The featured innovations include Sulfate-Free CNCs for Versatile Applications, Contact-Active Antimicrobial Nanocoating With Broad-Spectrum Protection, Nanoimprint...
29 Sep 2026 | Global | Market Research
Electronic Chemical Market, Global, 2025–2032
Electronic chemicals constitute a foundational input to semiconductor, printed circuit board (PCB), and flat panel display (FPD) manufacturing, underpinning the precision, purity, and performance requirements of increasingly sophisticated electronic devices. This study presents a comprehensive analy...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Outlook |
|---|---|
| Author | Aarti Siddhesh Chitale |
| Industries | Chemicals and Materials |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | Pharmaceutical Industry Outlook 2024 |
| Keyword 2 | Global Pharmaceutical Trends |
| Keyword 3 | Pharma Industry Analysis |
| List of Charts and Figures | Increasing M&As in Biopharma: Implications for Key Stakeholders, Global, 2023–2028~ Higher Focus on Precision Medicine: Implications for Key Stakeholders, Global, 2023–2028~ RWE Integration in Drug R&D: Implications for Key Stakeholders, Global, 2023–2028~ Pharmaceutical Industry: R&D Expenditure Forecast, Global, 2021–2028~ Pharmaceutical Industry: Drug Development Pipeline by Clinical Phase, Global, 2022–2023~ Pharmaceutical Industry: Therapeutic Segment Share, Global, 2024~ Pharmaceutical Industry: Therapeutic Segment Share, Global, 2028~ High Inflation and Global Recession: Implications for Key Stakeholders, Global, 2023–2028~ Intensification of Supply Chain Resilience Strategies: Implications for Key Stakeholders, Global, 2023–2028~ Sustainability Across the Pharma Value Chain: Implications for Key Stakeholders, Global, 2023–2028~ Pharmaceutical Industry: Revenue Forecast by Segment, Global, 2023 and 2024~ Pharmaceutical Industry: Revenue Forecast by Scenario, Global, 2021–2028~ Biologics: Revenue Forecast, Global, 2021–2028~ Small Molecules: Revenue Forecast, Global, 2021–2028~ Pharmaceutical Industry: Revenue Forecast by Region, Global, 2023–2024~ |
| Podcast | No |
| WIP Number | PFDE-01-00-00-00 |
Global Pharmaceutical Industry Outlook, 2024
$4,950.00
Special Price $3,712.50 save 25 %